146 related articles for article (PubMed ID: 16103083)
1. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2.
Titus B; Frierson HF; Conaway M; Ching K; Guise T; Chirgwin J; Hampton G; Theodorescu D
Cancer Res; 2005 Aug; 65(16):7320-7. PubMed ID: 16103083
[TBL] [Abstract][Full Text] [Related]
2. RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation.
Harding MA; Theodorescu D
Urol Oncol; 2007; 25(5):401-6. PubMed ID: 17826660
[TBL] [Abstract][Full Text] [Related]
3. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
[TBL] [Abstract][Full Text] [Related]
4. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
Gildea JJ; Seraj MJ; Oxford G; Harding MA; Hampton GM; Moskaluk CA; Frierson HF; Conaway MR; Theodorescu D
Cancer Res; 2002 Nov; 62(22):6418-23. PubMed ID: 12438227
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer.
Theodorescu D; Sapinoso LM; Conaway MR; Oxford G; Hampton GM; Frierson HF
Clin Cancer Res; 2004 Jun; 10(11):3800-6. PubMed ID: 15173088
[TBL] [Abstract][Full Text] [Related]
6. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.
Cho HJ; Baek KE; Park SM; Kim IK; Choi YL; Cho HJ; Nam IK; Hwang EM; Park JY; Han JY; Kang SS; Kim DC; Lee WS; Lee MN; Oh GT; Kim JW; Lee CW; Yoo J
Clin Cancer Res; 2009 Apr; 15(8):2612-9. PubMed ID: 19351766
[TBL] [Abstract][Full Text] [Related]
7. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
[TBL] [Abstract][Full Text] [Related]
8. Profiling the evolution of human metastatic bladder cancer.
Nicholson BE; Frierson HF; Conaway MR; Seraj JM; Harding MA; Hampton GM; Theodorescu D
Cancer Res; 2004 Nov; 64(21):7813-21. PubMed ID: 15520187
[TBL] [Abstract][Full Text] [Related]
9. RhoGDI2 as a therapeutic target in cancer.
Cho HJ; Baek KE; Yoo J
Expert Opin Ther Targets; 2010 Jan; 14(1):67-75. PubMed ID: 20001211
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis.
Niu H; Li H; Xu C; He P
Oncol Rep; 2010 Aug; 24(2):465-71. PubMed ID: 20596634
[TBL] [Abstract][Full Text] [Related]
11. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
12. Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis.
Hu LD; Zou HF; Zhan SX; Cao KM
Oncol Rep; 2007 Jun; 17(6):1383-9. PubMed ID: 17487395
[TBL] [Abstract][Full Text] [Related]
13. RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.
Said N; Sanchez-Carbayo M; Smith SC; Theodorescu D
J Clin Invest; 2012 Apr; 122(4):1503-18. PubMed ID: 22406535
[TBL] [Abstract][Full Text] [Related]
14. RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.
Griner EM; Dancik GM; Costello JC; Owens C; Guin S; Edwards MG; Brautigan DL; Theodorescu D
Mol Cancer Res; 2015 Mar; 13(3):483-92. PubMed ID: 25516960
[TBL] [Abstract][Full Text] [Related]
15. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
[TBL] [Abstract][Full Text] [Related]
16. Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.
Wu Y; Moissoglu K; Wang H; Wang X; Frierson HF; Schwartz MA; Theodorescu D
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5807-12. PubMed ID: 19321744
[TBL] [Abstract][Full Text] [Related]
17. Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer.
Said N; Smith S; Sanchez-Carbayo M; Theodorescu D
J Clin Invest; 2011 Jan; 121(1):132-47. PubMed ID: 21183790
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
19. PLCĪ³ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer.
Cho HJ; Baek KE; Nam IK; Park SM; Kim IK; Park SH; Im MJ; Ryu KJ; Yoo JM; Hong SC; Kim JW; Lee CW; Yoo J
Biochem Biophys Res Commun; 2011 Oct; 414(3):575-80. PubMed ID: 21986528
[TBL] [Abstract][Full Text] [Related]
20. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.
Moissoglu K; McRoberts KS; Meier JA; Theodorescu D; Schwartz MA
Cancer Res; 2009 Apr; 69(7):2838-44. PubMed ID: 19276387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
